GlucoseReady: A Digital Platform to Integrate Connected Device Data, ePRO, and Adherence Support in Clinical Trials

About this session

Session: ADAPTING NEW TECHNOLOGIES: AZ CASE STUDIES

Sponsored presentation.

Clinical ink’s GlucoseReady
TM
GCP-compliant digital platform integrates high velocity data from multiple connected devices including GCM and BGM with dynamic ePRO triggering. Validated personality profiling is incorporated to predict adherence and provide personalized support and lifestyle standardization. Integrated tools allow real-time aggregate data visualization and monitoring to drive insights and actions focused on adherence and safety, thus accelerating clinical development.

Speaker

• NA

  Nicholas Alp

  Chief Medical Officer · Clinical ink

  Speaker